Xeriant Reduces Debt and Reaches Amicable Settlement with Auctus Fund
Xeriant (OTCQB: XERI) announced on November 13, 2025 that it reached an amicable settlement with Auctus Fund, LLC, ending litigation between the parties and suspending further Auctus debt-to-equity conversions.
The agreement is described as reducing the company’s outstanding debt, removing a major overhang on the capital structure, and coordinating litigation efforts related to XTI Aircraft. Management said the settlement allows greater focus on NEXBOARD™ certification and commercialization of its advanced materials portfolio.
Xeriant (OTCQB: XERI) ha annunciato 11 novembre 2025 di aver raggiunto un accordo amichevole con Auctus Fund, LLC, ponendo fine alla controversia tra le parti e sospendendo ulteriori conversioni del debito di Auctus in azioni.
L'accordo è descritto come una riduzione dell’indebitamento della società, l’eliminazione di un importante ostacolo sul profilo patrimoniale e la coordinazione delle azioni legali relative a XTI Aircraft. Il management ha detto che l'accordo permette una maggiore concentrazione su certificazione NEXBOARD™ e sulla commercializzazione del portafoglio di materiali avanzati.
Xeriant (OTCQB: XERI) anunció el 13 de noviembre de 2025 que alcanzó un acuerdo amistoso con Auctus Fund, LLC, poniendo fin al litigio entre las partes y suspendiendo futuras conversiones de deuda de Auctus a acciones.
El acuerdo se describe como una reducción de la deuda pendiente de la empresa, la eliminación de un importante lastre en la estructura de capital y la coordinación de las acciones legales relacionadas con XTI Aircraft. La dirección indicó que el acuerdo permite centrar más esfuerzos en la certificación NEXBOARD™ y en la comercialización de su cartera de materiales avanzados.
Xeriant (OTCQB: XERI)는 2025년 11월 13일에 Auctus Fund, LLC와의 우호적 합의에 도달했다고 발표했고, 양 당사자 간의 소송을 종료하며 Auctus의 채무-주식 전환을 추가로 중단했습니다.
이 합의는 회사의 미지급 부채를 줄이고 자본 구조에 남아 있던 큰 부담을 제거하며 XTI Aircraft와 관련된 소송 활동을 조정하는 것으로 설명됩니다. 경영진은 이 합의가 NEXBOARD™ 인증 및 첨단 소재 포트폴리오의 상용화에 더 집중할 수 있게 한다고 말했습니다.
Xeriant (OTCQB: XERI) a annoncé le 13 novembre 2025 avoir trouvé un règlement à l’amiable avec Auctus Fund, LLC, mettant fin au litige entre les parties et suspendant les futures conversions de dette d'Auctus en actions.
L’accord est décrit comme une réduction de la dette en cours de la société, la suppression d’un important déséquilibre dans la structure du capital et la coordination des actions en justice liées à XTI Aircraft. La direction a déclaré que le règlement permettrait de se concentrer davantage sur la certification NEXBOARD™ et la commercialisation de son portefeuille de matériaux avancés.
Xeriant (OTCQB: XERI) gab am 13. November 2025 bekannt, dass es eine gütliche Einigung mit Auctus Fund, LLC erzielt hat, wodurch der Rechtsstreit zwischen den Parteien beendet und weitere Auctus-Schulden-zu-Eigenkapital-Umwandlungen ausgesetzt wurden.
Die Vereinbarung bezeichnet man als Reduzierung der ausstehenden Verschuldung des Unternehmens, das Entfernen eines großen Hemmschuhs für die Kapitalstruktur und die Koordinierung der Rechtsstreitigkeiten im Zusammenhang mit XTI Aircraft. Das Management erklärte, dass die Einigung eine stärkere Konzentration auf die NEXBOARD™-Zertifizierung und die Vermarktung seines Portfolios fortschrittlicher Materialien ermögliche.
Xeriant (OTCQB: XERI) أعلنت في 13 نوفمبر 2025 أنها توصلت إلى تسوية ودية مع Auctus Fund, LLC، مما أنهى الدعوى بين الطرفين وأوقف عمليات تحويل الدين إلى أسهم لـ Auctus.
وُصف الاتفاق بأنه يخفّض الدين المستحق على الشركة، ويزيل عبئاً كبيراً على هيكل رأس المال، ويُنسّق الجهود القانونية المتعلقة بـ XTI Aircraft. وقالت الإدارة إن التسوية تتيح تركيزاً أكبر على شهادة NEXBOARD™ وتجارة محفظة المواد المتقدمة لديها.
- Settlement suspends Auctus debt-to-equity conversions
- Agreement reduces outstanding company debt
- Removes a major capital-structure overhang for shareholders
- Frees resources to advance NEXBOARD certification and commercialization
- No quantified debt reduction or financial terms disclosed
- Potential remaining litigation tied to XTI Aircraft requires coordination
Move Strengthens Financial Position and Aligns Parties on XTI Litigation
BOCA RATON, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) ("Xeriant" or “the Company”), a company focused on the discovery, development, and commercialization of transformative technologies, today announced that it reached an amicable settlement agreement with Auctus Fund, LLC (“Auctus”), effectively ceasing litigation with Auctus, suspending further conversions by Auctus of debt into shares, reducing the Company’s outstanding debt, and coordinating the two parties’ litigation efforts related to XTI Aircraft.
“This settlement meaningfully strengthens our financial position by removing a major overhang and providing clarity around our capital structure,” stated Keith Duffy, CEO of Xeriant. “With this issue resolved, we can channel more of our resources and attention toward advancing NEXBOARD™ certification and accelerating the commercialization of our advanced materials portfolio.”
Please refer to the Form 8-K filed by Xeriant yesterday for more complete information regarding the settlement with Auctus.
To receive updates, visit www.xeriant.com/signup and follow Xeriant’s investor communications.
About Xeriant, Inc.
Xeriant, Inc. is dedicated to the discovery, development and commercialization of transformative technologies, including advanced materials, which can be successfully integrated and deployed across multiple industrial sectors. We seek to partner with and acquire strategic interests in visionary companies that accelerate this mission. Xeriant’s advanced materials line is marketed under the DUREVER™ brand, and includes NEXBOARD™, an eco-friendly, patent-pending composite construction panel made from plastic and fiber waste, designed to replace products such as drywall, plywood, OSB, MDF, MgO board and other materials used in construction.
For more information, please go to www.xeriant.com
SAFE HARBOR FORWARD-LOOKING STATEMENTS
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Xeriant, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations concerning our ability to attract investors.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make, and investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
This press release does not constitute an offer of any securities for sale.
Xeriant, Inc.
Investor Relations Dept.
(561) 491-9595
IR@xeriant.com
Xeriant.com
FAQ
What did Xeriant (XERI) announce on November 13, 2025 regarding Auctus Fund?
How does the Xeriant-Auctus settlement affect XERI shareholders and capital structure?
Will the Xeriant settlement with Auctus change plans for NEXBOARD certification or commercialization?
Did Xeriant disclose the financial terms or amount of debt reduced in the Auctus settlement?
Where can investors find more details about Xeriant’s settlement with Auctus (XERI)?
